- Irvine, CA US
- [email protected]
Charles Laverty, currently a senior vice president at Oppenheimer & Company, has a long history of working with companies that need reviving, especially in the health care industry. In 1994, Charles Laverty took over a small, struggling biomedical company called Davstar and merged it with five other companies to create a much larger company called Urohealth. He then renamed it Imagyn Medical Technologies, grew the company to more than $200 million and sold it in 2004 to Conmed Corporation.
Before that, Charles Laverty was recruited by Morgan Stanley to run Curaflex Health Services, Inc. In just three years, he increased the revenues from $2 million to $4 million and subsequently grew the business to more than $100 million, tripling the stock price. The company sold in 1994, and Laverty was named the 1992 Turnaround Entrepreneur of the Year by Inc. Magazine and Merrill Lynch.
Charles Laverty has served in various positions within the health care industry, including COO of Foster Medical and CEO of InfusionCare, both companies owned by Avon, Inc. He also sat on the board for various companies, including Pinnacle Micro, Coram Healthcare, New Day of American Heart, and Medication Delivery Devices.